Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Kissler

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Journal of Autoimmunity|December 11, 2002
Cross-reactivity and T-cell receptor antagonism of myelin basic protein-reactive T cells is modulated by the activation state of the antigen presenting cellStephan Kissler, Stephen M Anderton, David C Wraith
Journal of Visualized Experiments : Jove|December 5, 2022
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in MiceTaylor Stewart, Kevin Bode, Stephan Kissler, et al.
Genes and Immunity|August 23, 2019
The type 1 diabetes candidate gene Dexi does not affect disease risk in the nonobese diabetic mouse modelJanice M Nieves-Bonilla, Badr Kiaf, Cornelia Schuster, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
Beta Cells Deficient for <i>Renalase</i> Counteract Autoimmunity by Shaping Natural Killer Cell ActivityKevin Bode, Siying Wei, Isabella Gruber, et al.
Frontiers in Immunology|July 8, 2024
Beta cells deficient for <i>Renalase</i> counteract autoimmunity by shaping natural killer cell activityKevin Bode, Siying Wei, Isabella Gruber, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 26, 2011
IL-17 silencing does not protect nonobese diabetic mice from autoimmune diabetesJulie Joseph, Stefan Bittner, Fabian M P Kaiser, et al.
Nature Genetics|March 22, 2006
In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetesStephan Kissler, Patrick Stern, Kazue Takahashi, et al.
Current Opinion in Molecular Therapeutics|June 16, 2004
RNA interference for the identification of disease-associated genesAlessio Nencioni, Peter Sandy, Christopher Dillon, et al.
Diabetes|May 24, 2011
The soluble CTLA-4 splice variant protects from type 1 diabetes and potentiates regulatory T-cell functionKay D Gerold, Peilin Zheng, Daniel B Rainbow, et al.
Annual Review of Physiology|February 16, 2005
Rnai as an experimental and therapeutic tool to study and regulate physiological and disease processesChristopher P Dillon, Peter Sandy, Alessio Nencioni, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Journal of Autoimmunity|December 11, 2002
Cross-reactivity and T-cell receptor antagonism of myelin basic protein-reactive T cells is modulated by the activation state of the antigen presenting cellStephan Kissler, Stephen M Anderton, David C Wraith
Journal of Visualized Experiments : Jove|December 5, 2022
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in MiceTaylor Stewart, Kevin Bode, Stephan Kissler, et al.
Genes and Immunity|August 23, 2019
The type 1 diabetes candidate gene Dexi does not affect disease risk in the nonobese diabetic mouse modelJanice M Nieves-Bonilla, Badr Kiaf, Cornelia Schuster, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
Beta Cells Deficient for <i>Renalase</i> Counteract Autoimmunity by Shaping Natural Killer Cell ActivityKevin Bode, Siying Wei, Isabella Gruber, et al.
Frontiers in Immunology|July 8, 2024
Beta cells deficient for <i>Renalase</i> counteract autoimmunity by shaping natural killer cell activityKevin Bode, Siying Wei, Isabella Gruber, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 26, 2011
IL-17 silencing does not protect nonobese diabetic mice from autoimmune diabetesJulie Joseph, Stefan Bittner, Fabian M P Kaiser, et al.
Nature Genetics|March 22, 2006
In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetesStephan Kissler, Patrick Stern, Kazue Takahashi, et al.
Current Opinion in Molecular Therapeutics|June 16, 2004
RNA interference for the identification of disease-associated genesAlessio Nencioni, Peter Sandy, Christopher Dillon, et al.
Diabetes|May 24, 2011
The soluble CTLA-4 splice variant protects from type 1 diabetes and potentiates regulatory T-cell functionKay D Gerold, Peilin Zheng, Daniel B Rainbow, et al.
Annual Review of Physiology|February 16, 2005
Rnai as an experimental and therapeutic tool to study and regulate physiological and disease processesChristopher P Dillon, Peter Sandy, Alessio Nencioni, et al.
Pageof 4